Sign up to receive our twice-weekly e-Newsletter
PRO 140 and PRO 2000
PRO 140
is a humanized monoclonal antibody designed to block the ability of HIV to infect cells by inhibiting virus-cell binding.
Monoclonal Antibody PRO 140 Suppresses HIV Viral Load with Once-weekly Dosing
5-7-2010
Large Trial Finds
PRO 2000
Microbicide Is Ineffective in Preventing HIV Infection in Women
12-15-2009
Monoclonal Antibody
PRO 140
Demonstrates Good Tolerability and Potent Activity against CCR5-tropic HIV
10-06-2009
Newer Anti-HIV Drugs and How to Use Them: Part 2
6-22-2009
Experimental HIV Entry Inhibitor
PRO 140
Demonstrates Favorable Activity in Phase 2 Trial
11-08-2008
FDA-approved HIV
and AIDS Treatments
Protease Inhibitors
PIs
non Nucleoside Reverse
Transcriptase Inhibitors
nNRTIs
Nucleoside / Nucleotide
Reverse Transcriptase Inhibitors
NRTIs
Fixed-dose Combinations
Entry / Fusion Inhibitors
EIs
Integrase Inhibitors
Experimental Treatments
HIV and AIDS
Articles by Topic
Adverse Events
Opportunistic Infections
Metabolic Complications
Lipodystrophy - Fat Redistribution
Treatment Guidelines
Women/Children
